carbidopa has been researched along with Akinetic Autism in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ross, ED; Stewart, RM | 1 |
| Alexander, MP | 1 |
| Patterson, JF | 1 |
3 other study(ies) available for carbidopa and Akinetic Autism
| Article | Year |
|---|---|
Akinetic mutism from hypothalamic damage: successful treatment with dopamine agonists.
Topics: Adult; Akinetic Mutism; Bromocriptine; Carbidopa; Ergolines; Humans; Hypothalamic Neoplasms; Hypothalamus; Levodopa; Male; Methylphenidate; Postoperative Complications | 1981 |
Chronic akinetic mutism after mesencephalic-diencephalic infarction: remediated with dopaminergic medications.
Topics: Adult; Akinetic Mutism; Carbidopa; Cerebral Infarction; Chronic Disease; Diencephalon; Dopamine Agents; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Levodopa; Magnetic Resonance Imaging; Mesencephalon; Neuropsychological Tests; Pergolide | 2001 |
Akinetic parkinsonism and the catatonic syndrome: an overview.
Topics: Adult; Akinetic Mutism; Benztropine; Carbidopa; Catatonia; Humans; Levodopa; Male; Parasympatholytics; Parkinson Disease; Syndrome | 1986 |